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PCa presence; mean sensitivity and specificity were 38% 
(95% CI 13–75) and 95% (95% CI 88–98).  Conclusion: The use 
of varying assessment parameters strongly affects the diag-
nostic accuracy of MRI in the local staging of PCa. Hence, 
precise and standardized reporting regarding these param-
eters is important. In our study, using at least moderate prob-
abilities for PCa presence on MRI and prostatic sextants as 
ROI size was associated with best diagnostic performance. 
 © 2015 S. Karger AG, Basel 
 Background 
 MRI is generally accepted as the most accurate and 
promising imaging modality for assessing the local stag-
ing of prostate cancer (PCa)  [1] . It has passed through 
significant improvements over the last decades  [2], in-
cluding first and foremost a multi-parametric approach 
combining conventional MR with diffusion-weighted 
and dynamic contrast-enhanced imaging, hence, com-
bining morphological, micro-structural and even func-
tional information. With its high spatial resolution, it is 
able to detect PCa foci in difficult anatomical locations 
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 Abstract 
 Introduction: There is a broad variability in the accuracy lev-
els of MRI with regard to the local staging of prostate cancer 
(PCa).  Methods: A prospective analysis was conducted in pa-
tients with localized PCa with MRI of the prostate before rad-
ical prostatectomy. MRI and pathology findings were inde-
pendently reviewed and reported based on a standardized 
map of the prostate with 16 regions of interest (ROIs). Diag-
nostic accuracy analysis of the MRI was performed using 
varying prostate-subpart sizes and varying cutoffs for the ra-
diological probability for PCa presence.  Results: Seventy 
four patients were included. Using varying cutoff probabili-
ties and varying sizes of prostate-subparts resulted in a 
broad range of sensitivity (6–88%) and specificity (38–100%). 
Lower probabilities of PCa presence and larger prostate-sub-
parts resulted in higher sensitivity but lower specificity and 
vice versa. Best diagnostic performance was achieved by us-
ing prostate sextants and at least moderate probabilities for 
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within the prostatic gland (i.e. the anterior zone)  [3] and 
it even has the potential to assess the aggressiveness of 
PCa  [4–8] .
 However, with MRI the reading and interpretation of 
the images is much more operator dependent than with 
other imaging modalities  [9] . In the absence of generally 
accepted guidelines or standards for the acquisition and 
interpretation of prostate MR images, the quality of the 
image reading, its reproducibility and reduction of mis-
interpretation are important and mandatory prerequi-
sites for providing high quality care to PCa patients  [10] .
 To further improve on these crucial points, clinical 
studies comparing MRI findings to their gold standard, 
and the histological specimen, providing the essential and 
ultimate accuracy of the method, are important. The aim 
of our study was to investigate the influence of different 
factors on the diagnostic accuracy of MRI in the local 
staging of PCa as well as to define MRI performance set-
tings for best diagnostic results.
 Patients and Methods 
 This is a retrospective analysis of a prospectively collected data 
set. Patients with clinical localized PCa with preoperative MRI be-
fore undergoing radical prostatectomy have been included be-
tween January 2011 and January 2012.
 All patients underwent a standardized multiparametric MRI of 
the prostate on a 1.5-tesla MR system (Signa EchoSpeed EXCITE 
HD; GE Healthcare, Milwaukee, Wis., USA) with the use of an 
endo-rectal coil. The standardized multiparametric image proto-
col consisted of unenhanced multiplanar T2-weighted and diffu-
sion-weighted sequences. Following intravenous injection of 
gadoterate meglumine (Dotarem, Guerbet), dynamic contrast-en-
hanced MRI with fat-suppressed T1-weighted images was per-
formed.
 Radical prostatectomy was done in a robotic-assisted laparo-
scopic way in all cases. This study has been conducted in accor-
dance with the rules of the local ethical committee.
 Interpretation and Matching of Findings by Radiologist and 
Pathologist 
 One MRI-experienced radiologist and one experienced genito-
urinary pathologist interpreted their findings independently and 
were blinded to the other’s findings, and findings were recorded 
along a sophisticated scheme with 16 regions of interest (ROIs) as 
recommended in a European consensus meeting  [11] . The radi-
ologist indicated the probability of the presence of PCa on a 4-point 
scale (0 = no indication for PCa presence, 1 = low probability of 
PCa presence, 2 = moderate probability of PCa presence, 3 = high 
probability of PCa presence). A specific focus was set on the pres-
ence of hematoma, indicating the probability of its presence on a 
4-point scale (0 = no hematoma, 1 = small hematoma, 2 = moder-
ate hematoma, 3 = extensive hematoma). Further, an assessment 
of extra-capsular growth and seminal vesicle invasion was done on 
a per-patient level using a 2-point scale (0 = condition not present, 
1 = condition present).
 The pathologist first of all performed the standardized workup 
of the prostatectomy specimen. He recorded the tumor extension 
and Gleason score by the routine protocol applied at the Univer-
sity Hospital of Zurich. Additionally, he recorded his findings 
along the 16 ROI scheme by which he indicated the presence of 
cancer for each ROI using a 2-point scale (0 = no tumor present, 
1 = tumor present). This procedure offered a unique comparison 
of MR findings with final pathology.
 Statistical Analysis 
 We assessed the influence of different cutoffs for the probabil-
ity of PCa presence on MRI (low, meaning ‘no indication’ vs. ‘at 
least low’ probability for PCa presence on MRI; moderate, mean-
ing ‘at most low’ vs. ‘at least moderate’ probability for PCa pres-
ence on MRI; high, meaning ‘at most moderate’ vs. ‘at least high’ 
probability for PCa presence on MRI) and varying ROI sizes (pros-
tate halfs, prostate sextants and prostate 16th parts) on the diag-
nostic performance of the MRI. For the analysis on prostate half 
level, we grouped the 16 ROIs into corresponding left and right 
parts, for the analysis on prostate sextant level, accordingly to apex, 
middle and basic parts, each left and right. We used the different 
probabilities of PCa presence on MRI  as cutoff between normal 
and suspicious MR findings (in detail: no vs. at least low probabil-
ity; at most low vs. at least moderate probability; at most moderate 
vs. at least high probability of PCa presence on MRI). Since ROIs 
are clustered within patients, we analyzed sensitivity and specific-
ity per patient and reported them as means with 95% bootstrap CI. 
Values between different situations were compared using the Wil-
coxon signed ranks test. 
 We decided not to perform positive predictive values (PPV) 
and negative predictive values (NPV) analysis on prostate subpart 
level due to the very high prevalence of PCa positive ROIs of almost 
70% in this setting, resulting in misleadingly high PPV.
 Furthermore, in a clinical setting optimized for the best overall 
diagnostic performance of MRI (in detail: using prostate sextants 
and at least moderate probability of PCa presence on MRI), we 
calculated unadjusted and adjusted OR using clustered logistic re-
gression. We adjusted for various variables (age, body mass index 
[BMI], prostate volume, preoperative prostate specific antigen 
[PSA], primary Gleason pattern, secondary Gleason pattern, Glea-
son sum score and presence of post-biopsy hematoma). Specifi-
cally, MRI findings have been used as independent variable, while 
pathology findings and one of age, BMI, prostate volume, preop-
erative PSA, presence of post-biopsy hematoma, primary and sec-
ondary Gleason pattern and Gleason score as dependent variables, 
as well as a robust standard error with patient ID as cluster were 
performed. To assess the influence of the level of probability of PCa 
presence on MRI on the OR, we repeated the analysis as described 
earlier using high probability of PCa presence on MRI.
 Finally, sensitivity, specificity, PPV and NPV for extra-capsular 
tumor growth and seminal vesicle invasion were analyzed at a pa-
tient level, using a 2-point scale (0 = condition not present, 1 = 
condition present) on MRI and values are reported with Wilson 
95% CI.
 p values <0.05 were considered statistically significant. Statisti-
cal analyses were performed using STATA 11.2 (StataCorp, Col-
lege Station, Tex., USA) and SPSS Statistics version 22 (IBM Corp., 
Armonk, N.Y., USA).
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 Results 
 A total of 74 patients were included in the study. The 
characteristics of these patients are summarized in  ta-
ble 1 . The histological prevalence of PCa based on 16 ROI 
was 48% (573 of 1,184), based on sextants 69% (305 of 
444) and based on prostate halfs 95% (140 of 148).
 MRI identified PCa presence in 64% (47 of 74) using 
low, 34% (34 of 74) using moderate and 30% (30 of 74) 
using high probabilities for PCa presence on MRI as cut-
off between normal and suspicious MR findings.
 Both, different probabilities of PCa presence on MRI 
as cutoff between normal and suspicious MR findings as 
well as different sizes of ROIs influenced sensitivity and 
specificity profoundly ( table  2 ). Specifically, sensitivity 
ranged from 6 to 88% and specificity from 38 to 100%, 
respectively. Optimizing one resulted in the deterioration 
of the other. Using lower probabilities of PCa presence on 
MRI as cutoff between normal and suspicious findings on 
MRI resulted in a higher sensitivity but a lower specific-
ity, whereas using higher probabilities for PCa presence 
on MRI resulted in lower sensitivity but higher specificity, 
as we expected by definition. Applying smaller ROIs, re-
spectively, resulted in lower sensitivity and higher speci-
ficity and vice versa. Whereas the trend in sensitivity was 
generally statistically significant (all p values <0.001), the 
trend for specificity showed only partial significance 
when using low probability for PCa presence on MRI as 
cutoff between normal and suspicious MR findings (pros-
tate sextants compared to prostate sixteenth parts p  = 
0.003, prostate halfs compared to prostate sixteenth parts 
p = 0.046 and prostate halfs compared to prostate sextants 
p = 0.057).
 Best diagnostic performance was achieved using pros-
tate sextants and at least moderate probability for PCa 
presence on MRI ( table 2 ). The raw sensitivity was 38% 
  Mean Median Range
Age, years 62 64 42–74
BMI, kg/m2 26.5 26.2 20.1–35.5
PSA pre-operative, ng/ml* 8.7 7.2 0.75–59.9
Time from biopsy to MRI, days 66 46 6–366
Time from MRI to operation, days 30 20 1–138
Postoperative data
Gleason score 7.2 7 6–9
Non-organ confined disease (>pT2), % (n) 23 (17 of 74)
Seminal vesicle invasion, % (n) 8 (6 of 74)
* One man with androgen deprivation therapy (PSA = 0.75 ng/ml).
Cutoff for the probability for 
PCa presence on MRI
Size of ROIs
‘Normal’ vs. ‘suspicious’ Prostate-1/2 Prostate-1/6 Prostate-1/16
‘No indication’ vs. ‘at least low’
Sensitivity, % (95% CI) 88 (63–88)6 63 (25–88)2 50 (19–81)1
Specificity, % (95% CI) 38* 73 (55–88)1 86 (72–95)1
‘At most low’ vs. ‘at least moderate’
Sensitivity, % (95% CI) 50 (13–88)7 38 (13–75)2 31 (6–63)2
Specificity, % (95% CI) 88* 95 (88–98)3 98 (93–99)3
‘At most moderate’ vs. ‘at least high’
Sensitivity, % (95% CI) 25 (13–63)8 13 (13–38)4 6 (6–19)4
Specificity, % (95% CI) 100* 98 (90–98)5 98 (93–98)5
 1 Based on 1,000 bootstrap samples (bts), 2 976 bts, 3 899 bts, 4 636 bts, 5 668 bts, 6 649 
bts, 7 996 bts, 8 864 bts.
* Due to low number of patients with negative ROIs (n = 8) bootstrap not valid.
Table 1.  The basic characteristic of the study 
population (n = 74)
Table 2.  Impact of different cutoffs for the 
PCa presence on MRI and different sizes of 
ROIs on sensitivity and specificity
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(116 of 305) and specificity 95% (132 of 139). Results for 
mean sensitivity and specificity as well as the ORs are 
summarized in  table 3 . An OR of 4.82 means that the odds 
of a ROI classified as ‘at least moderate probability of PCa 
presence in MRI’ being truly cancer affected in final pa-
thology is almost 5 times the odds of an ROI with ‘no or 
low probability of PCa presence in MRI’. Of the depen-
dent variables, age, BMI, prostate volume, preoperative 
PSA, presence of post-biopsy hematoma, primary and 
secondary Gleason pattern and Gleason score, only pros-
tate volume and the primary Gleason pattern showed to 
have an influence on the outcome of interest; hence, the 
OR adjusted for prostate volume and the predominant 
Gleason pattern was 4.58 (95% CI 2.34–8.98; p < 0.001). 
Using only high probabilities for PCa presence in MRI 
resulted in an improvement of the OR: the unadjusted OR 
was 6.65 (95% CI 2.18–20.3; p = 0.001) and adjusted for 
prostate volume and the predominant Gleason pattern 
5.70 (95% CI 1.76–18.4; p = 0.004).
 Finally, results for extra-capsular tumor growth and 
seminal vesicle invasion on patient level are summarized 
in  table 4 .
 Discussion 
 Our study demonstrates that in the MRI of the pros-
tate, the use of varying cutoffs for the probability for PCa 
presence as well as varying sizes of ROIs influenced the 
diagnostic accuracy of MRI both independently. Almost 
the full range of sensitivity and specificity can be 
achieved, dependent of the specific constellation of these 
2 criteria used, by which sensitivity and specificity were 
mainly dependent on each other; that is, optimization of 
one lead to the deterioration of the other. Hence, a pre-
cise reporting in regard to these parameters – that is, 
which cutoff has been applied for the assessment – by 
radiologists is of utmost importance for the clinician in 
order to be able to interpret MRI results correctly. Our 
findings highlight the importance for the implementa-
tion of standardized MRI reporting guidelines. Further-
more, adherence to such reporting guidelines would 
help to make the results of respective studies much more 
comparable.
 Since specificity is the main strength of MRI, assess-
ment criteria should be optimized here for. Our findings 
show that using at least a moderate probability of PCa 
presence in MRI results in excellent specificity. However, 
using at least a high probability did not improve the spec-
ificity of the MRI further significantly but leads to a pro-
found deterioration of sensitivity. Further, the use of 
smaller ROIs results in higher specificity while the mis-
match increases with decreasing ROIs size; hence, a clin-
ically meaningful cutoff must be defined. As a result of 
this study, a prostate sextant displayed a reasonable ROI 
size.
 The observed inverse association of sensitivity and 
specificity when using different probabilities of PCa 
presence in MRI is what we would expect by defini-
tion. This means that lower probabilities result in better 
sensitivity and worse specificity and vice versa. How-
ever, the inverse association with varying ROI sizes 
needs explanation. We believe that this effect is due to 
different grades of mismatch. The mismatch between 
MRI and pathological findings will increase when using 
smaller ROIs and decrease when using larger ROIs, 
since the use of larger ROIs will result in blurring 
and  true precision will not be achieved. Mainly, false 
negative findings will be reduced with consequent ef-
fects of sensitivity and specificity.
 For clinical practice, our results are of importance 
since they help to explain the broad spectrum of diag-
nostic accuracy for prostate MRI found in the current 
literature. Recently, a systematic review and meta-anal-
Table 3.  Results for best diagnostic performance using prostate 
sextants as ROIs and at least moderate cutoff probability for PCa 
presence on MRI
95% CI p value
Sensitivity*, % 38 13–75
Specificity*, % 95 88–98
Unadjusted OR 4.82 2.49–9.36 <0.001
Adjusted OR** 4.58 2.34–8.98 <0.001
 * Mean values taking clustering into account.
** Adjusted for Gleason pattern 1 and prostate volume.
Table 4.  Results for extra-capsular tumor growth and seminal ves-
icle invasion on patient level
Extra-capsular 
tumor growth
 Seminal vesical 
invasion
% 95% CI  % 95% CI
Prevalence 23 8
Sensitivity 12 3–34 33 10–70
Specificity 96 88–99 99 92–100
PPV 50 8–92 67 12–96
NPV 79 67–87 94 86–98
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ysis of the topic has been published  [12] . The study in-
cluded 21 papers for analysis and the pooled sensitivity 
and specificity were 62% (95% CI 61–64) and 90% 
(95% CI 89–90). However, they found a broad variabil-
ity within these results with sensitivity and specificity 
ranging from 29 to 94% and 39–100%, respectively. 
These results show the problem of inaccuracy in an im-
pressive way and underline the importance of under-
standing the reasons for such variability. Whereas in 
most studies the size and shape of the ROIs are de-
scribed in detail, the MRI assessment criteria often re-
main vague.
 As described earlier, various previous studies showed 
the influence of the Gleason score (as a descriptive vari-
able for PCa aggressiveness) on the diagnostic perfor-
mance of MRI  [4–8] as well as the ability of MRI to assess 
the aggressiveness of PCa, respectively. In contrast to 
these findings, our results suggest that not the Gleason 
sum score but rather the primary Gleason pattern seems 
to affect the diagnostic performance of the MRI. Hence, 
the aggressive pattern must have a certain volume to be 
identifiable by MRI. As an example, a Gleason score 8 
PCa can easily be missed on MRI in case of a predominant 
Gleason 3 pattern and a minor Gleason 5 pattern that is 
only sparsely present.
 Since the technical potential of MRI seems to be far 
away from being fully exploited, multi-parametric MRI 
still harbors an enormous potential to revolutionize 
PCa management. Especially the ability to assess aggres-
siveness and the ability to localize foci with high or 
higher aggressiveness within the prostate gland could 
improve the safety of gland sparing treatment approach-
es (like active surveillance or focal therapy) and there-
fore help to reduce overtreatment  [13] . Besides techni-
cal improvements, the development of guidelines for a 
standardized image acquisition as well as guidelines for 
a more standardized interpretation and reporting of 
prostate MRI findings would be helpful to provide use-
ful and reliable information for clinicians. To this end, 
further clinical studies comparing MRI findings to step-
section histologic specimens are required during the 
coming years.
 Strengths 
 Using a sophisticated method with corresponding 
ROIs to compare MR findings to histopathological spec-
imens is clearly the main strength of our study and this 
allowed for a unique possibility to assess diagnostic ac-
curacy, on patient as well as different prostate subpart 
levels. Furthermore, the approach allowed assessing the 
influence of MRI assessment criteria as well as the size 
of ROIs on diagnostic performance of MRI in a direct 
way.
 Limitations 
 Some limiting factors must be discussed as well. First 
of all, the number of included patients is moderate mak-
ing sub-analysis in different patient groups unreliable. 
Prevalence of PCa is high, even on prostate subpart levels, 
limiting the predictive values. Finally, we did not have a 
Gleason Scoring on the subpart level of the prostate (i.e. 
sextants as ROIs) but rather on the patient level. Hence, 
an adjusted analysis on the subpart level with correspond-
ing Gleason scores within these subparts was not possible, 
and Gleason Scoring on patient level was taken as proxy 
for Gleason score on the subpart level. Hence, inaccuracy 
in the assessment of the influence of Gleason score and 
the corresponding Gleason patterns and MR findings 
cannot be excluded completely.
 Conclusion 
 The use of varying assessment parameters strongly af-
fects the diagnostic accuracy of MRI in the local staging 
of PCa. Hence, a precise and standardized reporting with 
regard to these parameters is important for the correct 
interpretation of MRI results. In our study, using at least 
moderate probabilities for PCa presence on MRI and 
prostatic sextants as ROI size was associated with best di-
agnostic performance.
 Disclosure Statement 
 None. 
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